Indications and uses
Temporarily relieves minor aches and pains due to: headache, toothache, backache, menstrual cramps, muscular aches, minor pain of arthritis
Temporarily relieves minor aches and pains due to: headache, toothache, backache, menstrual cramps, muscular aches, minor pain of arthritis
Do not take more than directed Adults and children 12 years and over: take 2 caplets every 8 hours while symptoms persist; Children under 12 years ask a doctor Do not take more than 6 caplets in 24 hours, unless directed by a doctor
Active Ingredients (in each caplet) Purpose
Acetaminophen 250 mg Pain reliever
Ibuprofen 125 mg (NSAID**) Pain reliever
**nonsteroidal anti-inflammatory drug
Pain Reliever
Temporarily relieves minor aches and pains due to: headache, toothache, backache, menstrual cramps, muscular aches, minor pain of arthritis
Acetaminophen liver damage warning: This product contains acetaminophen. Severe liver damage may occur if you take: with other drugs containing acetaminophen, more than 6 caplets in 24 hours, which is the maximum daily amount for this product, 3 or more alcoholic drinks every day while using this product.
Acetaminophen allergy alert: may cause severe skin reactions. Symptoms include, skin reddening, blisters, rash.
If skin reactions occurs, stop use and seek medical help right away.
NSAID allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin.
Symptoms may include: hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, blisters
If an allergic reaction occurs, stop use and seek medical help right away.
NSAID stomach bleeding warnings: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you: are age 60 or older, have had stomach ulcers or bleeding problems, take a blood thinning (anticoagulant) or steroid drug, take other drugs containing prescription or nonprescription NSAIDs [aspirin, ibuprofen, naproxen, or others], have 3 or more alcoholic drinks every day while using this product, take more or for a longer time than directed.
Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
Do not use, with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist, if you have ever had an allergic reaction to acetaminophen or any other pain reliever, right before or after heart surgery.
Ask a doctor before use if:
You have liver disease, stomach bleeding warning applies to you, you have problems or serious side effects from taking pain relievers, you have a history of stomach problems such as heartburn, you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke, you are taking a diuretic.
Ask a doctor or pharmacist before use if you are:
Under a doctor’s care for any serious condition, taking aspirin for heart attack or stroke, because ibuprofen may decrease this benefit of aspirin, taking any other drug.
When using this product, take with food or milk if stomach upset occurs.
Stop use and ask a doctor if, you experience any of the following signs of stomach bleeding:
feel faint, vomit blood, have bloody or black stools, have stomach pain that does not get better, you have symptoms of heart problems or stroke: chest pain, trouble breathing, weakness in one part or side of body, slurred speech, leg swelling, pain gets worse or lasts more than 10 days, redness or swelling is present in the painful area, any new symptoms appear.
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
Adults and children 12 years and over: take 2 caplets every 8 hours while symptoms persist;
Children under 12 years ask a doctor
Inactive ingredients:
carnauba wax, colloidal silicon dioxide, croscarmellose sodium, crospovidone, ferric oxide red, ferric oxide yellow, hypromellose, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, povidone, pregelatinized starch, sodium lauryl sulfate, stearic acid and titanium dioxide.
Call 1-800-997-5561, Monday through Friday, 9AM-5PM EST.
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
Relabeling of sections to conform to SPL requirements
Period Pills by Biikay
Pain Reliever
| Class | Version | Type | Effective |
|---|---|---|---|
| IBUPROFEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0385576101369 | GTIN-13: 0385576101369 EAN-13: 0385576101369 GTIN-12: 385576101369 UPC-A: 385576101369 GTIN storage (14 digits): 00385576101369 | Label.jpg |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85576-101 | 85576-101-36 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| CROSPOVIDONE | 2S7830E561 | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| FERRIC OXIDE YELLOW | EX438O2MRT | IACT |
| CARNAUBA WAX | R12CBM0EIZ | IACT |
| FERRIC OXIDE RED | 1K09F3G675 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| POVIDONE | FZ989GH94E | IACT |
| SODIUM LAURYL SULFATE | 368GB5141J | IACT |
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| POLYDEXTROSE | VH2XOU12IE | IACT |
| IBUPROFEN | WK2XYI10QM | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 6 | 2026-03-22 | full-release | 2026-06-01 01:51:03 |
| 5 | 2026-01-02 | monthly-update | 2026-06-03 17:51:16 |
| 4 | 2025-12-24 | monthly-update | 2026-06-03 17:47:03 |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216592-001 | ACETAMINOPHEN AND IBUPROFEN | ACETAMINOPHEN; IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | 9b2671bbb829… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216592-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2023-07-13 | a50c72e98297… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Period Pills by Biikay | ACETAMINOPHEN, IBUPROFEN | Kai Squared | 40d2ae73-82cf-3fa1-e063-6394a90a9ea2 | 2026-06-01 | Warnings | 85576-101-36 85576-101 85576010136 533260ee-9c48-fe57-e063-6394a90a9130 40d2ae73-82cf-3fa1-e063-6394a90a9ea2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.